Hermetica Superfood Encyclopedia
The Short Answer
Chaetoceros muelleri extracts contain sulfated polysaccharides (CMSPs, Mw 4.13 kDa), β-glucans (~0.41 g/L), and phenolic compounds (up to 14.91 μg/mg GAE) that collectively drive antioxidant activity through free radical stabilization facilitated by sulfate groups and low-molecular-weight chain conformations. In vitro assays demonstrate ABTS radical scavenging activity up to 94.59% at 2 mg/mL and a glycemic index of 49 for purified CMSPs, positioning this diatom extract as a candidate low-glycemic antioxidant nutraceutical, though no human clinical trials have yet been conducted.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary KeywordChaetoceros muelleri extract benefits
Chaetoceros muelleri microalgae extract — botanical close-up
Health Benefits
**Antioxidant Protection**
Sulfated polysaccharides (CMSPs) and β-glucans synergize to scavenge free radicals, with ABTS inhibition reaching 94.59 ± 0.04% at 2 mg/mL and DPPH inhibition up to 65.33 ± 2.90% at 10 mg/mL in nitrogen-enriched biomass extracts.
**Low Glycemic Index Support**
Purified CMSPs exhibit a glycemic index of 49, classifying them as a low-GI carbohydrate fraction that may blunt postprandial glucose responses, though this has been demonstrated only in in vitro starch digestion assays rather than human studies.
**Immune Modulation Potential**: β-Glucan content (~0
41 g/L in culture) suggests capacity to engage pattern recognition receptors such as Dectin-1 on innate immune cells, a mechanism well-characterized for fungal and cereal β-glucans, though direct immunomodulatory studies on C. muelleri β-glucans remain unpublished.
**Anti-Inflammatory Candidate**
Sulfated polysaccharides from related diatom species are known to inhibit pro-inflammatory cytokine cascades; CMSPs from C. muelleri share structural characteristics (sulfate groups confirmed by FTIR bands at 590–3405 cm⁻¹) that underpin this class of activity, pending direct mechanistic validation.
**Protein-Rich Nutritional Supplement**
Biomass cultivated in nitrogen-enriched media yields up to 94.84 ± 0.08 mg protein per gram dry weight, representing a high-quality marine protein source with potential applications in functional food formulation.
**Gastrointestinal Safety and Prebiotic Potential**
CMSPs demonstrated non-cytotoxicity against CCD-841 human colon epithelial cells in vitro, and the low-molecular-weight sulfated fraction (4.13 kDa) exhibits solubility characteristics consistent with prebiotic fermentability, though gut microbiome interaction studies have not been performed.
**Phenolic-Mediated Cellular Defense**: Total phenolic content peaking at 14
91 ± 0.97 μg/mg GAE in nitrogen-enriched cultures (equivalent reducing power 49.44–53.23 mg ascorbic acid) indicates meaningful hydroxyl radical-quenching capacity attributable to chromophore- and hydroxyl-bearing phenolic metabolites.
Origin & History
Natural habitat
Chaetoceros muelleri is a marine centric diatom found broadly in coastal and open ocean environments worldwide, particularly in temperate and tropical marine waters. It is commercially cultivated in controlled photobioreactor or open raceway pond systems using nutrient-defined media such as Guillard's f/2 medium, reaching stationary-phase cell densities of 1.5–3.15 × 10⁶ cells/mL within 3–7 days. The species is widely used in aquaculture as a live feed for bivalve larvae and is increasingly studied for its nutraceutical and bioactive compound potential.
“Chaetoceros muelleri has no documented history of use in any traditional medicine system, including Ayurveda, Traditional Chinese Medicine, or indigenous marine food cultures, as it exists at microscopic scale and was not identifiable or isolable without modern microscopy and cultivation technology. Its recognition as a commercially significant organism dates to 20th-century aquaculture research, where it became a standard live feed species for oyster, clam, and scallop hatcheries due to its rapid growth, high nutritional density, and palatability to bivalve larvae. Contemporary scientific interest in its bioactive compounds, particularly sulfated polysaccharides and β-glucans, emerged from broader research into marine microalgae as sustainable sources of novel nutraceuticals and functional food ingredients. No historical pharmaceutical monographs, ethnobotanical records, or traditional preparation methods exist for this species.”Traditional Medicine
Scientific Research
The published evidence base for Chaetoceros muelleri bioactive extracts is limited to a small number of in vitro and cultivation optimization studies, with no peer-reviewed human clinical trials identified as of the knowledge cutoff. Available studies characterize biomass composition under varied nitrogen regimes and physicochemically describe purified CMSPs using FTIR, HPLC, dynamic light scattering, and scanning electron microscopy, establishing proof-of-concept antioxidant and low-glycemic-index properties. Cytotoxicity screening against CCD-841 human colon epithelial cells provides a preliminary safety signal but does not constitute clinical evidence, and aquaculture growth data (cell density up to 3.15 × 10⁶ cells/mL) are not translatable to human pharmacology. The overall evidence quality is preclinical, and the field requires dose-response studies in animal models followed by pharmacokinetic and efficacy trials in humans before any therapeutic or supplemental claims can be substantiated.
Preparation & Dosage
Traditional preparation
**Laboratory Biomass Powder**
Cultivated in Guillard's f/2 seawater medium to stationary phase (day 3–7), harvested by centrifugation, and freeze-dried; no standardized commercial dose established.
**Purified Sulfated Polysaccharides (CMSPs)**
2 mg/mL (ABTS assay) and 10 mg/mL (DPPH assay) in vitro — these are analytical concentrations, not human doses
Extracted from dry biomass with 2.2% w/w yield; characterized at 4.13 kDa; studied at .
**Crude Aqueous Extract**
2–10 mg/mL in antioxidant assays; no equivalent oral supplemental dose range has been determined for humans
Used at .
**No Standardization Available**
No commercial product standardization percentage (e.g., % sulfated polysaccharides or % β-glucan) has been established or validated for this species.
**Timing and Form Notes**
Potential food additive or nutraceutical use as a low-GI carbohydrate ingredient is speculative; low Mw of CMSPs (4.13 kDa) suggests favorable aqueous solubility, but oral bioavailability after digestion has not been measured.
**Aquaculture Live Feed**
Administered as live algal culture (1–3 × 10⁶ cells/mL) to bivalve larvae; this application is entirely distinct from human supplemental use.
Nutritional Profile
Protein content varies significantly with cultivation nitrogen availability: up to 94.84 ± 0.08 mg/g dry weight under nitrogen-enriched conditions (T1) versus ~31 mg/g under alternative nutrient regimes. β-Glucan content is approximately 0.41 ± 0.01 g/L in culture regardless of nitrogen treatment. Total phenolic content peaks at 14.91 ± 0.97 μg/mg GAE (T1), with an ascorbic acid equivalent reducing power of 49.44–53.23 mg/g, indicating moderate phenolic-driven antioxidant capacity. Sulfated polysaccharides (CMSPs) constitute 2.2% of dry biomass by weight with a sulfate degree of 0.10. Lipid, carotenoid, chlorophyll, vitamin, and mineral profiles have not been quantified in published literature for this species, limiting a complete nutritional characterization. Bioavailability of CMSPs after oral ingestion is unknown; the low molecular weight (4.13 kDa) and high aqueous solubility favor intestinal accessibility in principle.
How It Works
Mechanism of Action
The antioxidant activity of Chaetoceros muelleri extracts operates through at least two structurally distinct mechanisms: (1) CMSPs with a weight-average molecular weight of 4.13 kDa and polydispersity index of 2.12 adopt compact chain conformations with a hydrodynamic radius of 1.33 nm, enabling efficient electron donation and free radical stabilization via negatively charged sulfate ester groups (confirmed by FTIR absorption at 590 and 1240 cm⁻¹); and (2) β-glucans independently contribute to radical scavenging as evidenced by the highest ABTS activity (94.59%) occurring in the treatment condition (T3) with the lowest total phenolic content, decoupling phenolic-mediated from polysaccharide-mediated antioxidant capacity. Phenolic compounds bearing hydroxyl and chromophore substituents provide additional hydrogen atom transfer (HAT) and single electron transfer (SET) radical quenching activity proportional to their concentration, with T1 nitrogen-enriched extracts showing 3.5-fold higher TPC than other cultivation conditions. No receptor-level, enzyme-inhibition, or gene-expression data have yet been published for this species, and mechanistic extrapolation from structurally analogous marine polysaccharides must be applied cautiously.
Clinical Evidence
No clinical trials in human subjects have been conducted on Chaetoceros muelleri extracts or purified CMSPs. In vitro findings establish antioxidant potency (up to 94.59% ABTS scavenging), a low glycemic index of 49 for CMSP fractions, and non-cytotoxicity in colon cell lines, but these outcomes cannot be directly extrapolated to clinical efficacy or safety in humans. Effect sizes from in vitro assays are promising relative to comparator diatom polysaccharides, with CMSPs outperforming some structurally related species in free radical stabilization at comparable concentrations. Clinical confidence remains very low; this ingredient should be categorized as a preclinical candidate ingredient requiring systematic toxicology, bioavailability, and efficacy evaluation before supplemental use recommendations can be made.
Safety & Interactions
The available safety data for Chaetoceros muelleri extracts are limited to a single in vitro cytotoxicity assay demonstrating that purified CMSPs are non-cytotoxic to CCD-841 human colon epithelial cells, which represents a minimal safety signal insufficient to characterize the human safety profile. No in vivo animal toxicology studies, maximum tolerated dose determinations, genotoxicity assays, or human adverse event data have been published. Drug interactions, contraindications, effects during pregnancy or lactation, and maximum safe doses have not been investigated, and the sulfated polysaccharide class in other marine organisms has shown anticoagulant properties at higher molecular weights — a theoretical interaction risk with anticoagulant medications (e.g., warfarin, heparin) that cannot be confirmed or excluded for CMSPs at 4.13 kDa without dedicated coagulation studies. Individuals with shellfish or marine algae allergies, immunosuppression, or bleeding disorders should avoid uncharacterized marine microalgae extracts until comprehensive safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Chaetoceros muelleriChaetoceros muelleri LemmermannC. muellerimarine diatom extractCMSP
Frequently Asked Questions
What are the main bioactive compounds in Chaetoceros muelleri extract?
Chaetoceros muelleri extract contains sulfated polysaccharides (CMSPs, 2.2% yield from dry biomass, Mw 4.13 kDa), β-glucans (~0.41 g/L in culture), and phenolic compounds (up to 14.91 μg/mg GAE under nitrogen-enriched growth). Protein content can reach 94.84 mg/g dry weight when cultivated in nitrogen-rich media. These compounds collectively drive the extract's antioxidant and low-glycemic-index properties observed in laboratory studies.
Is Chaetoceros muelleri extract safe to consume as a supplement?
Current safety data are limited to an in vitro test showing purified CMSPs are non-cytotoxic to human colon epithelial cells (CCD-841 line); no human trials, animal toxicology studies, or maximum safe dose data exist. The sulfated polysaccharide class found in other marine organisms can theoretically interact with anticoagulant medications, so individuals on blood thinners should exercise caution. Comprehensive human safety evaluation has not been performed, and this ingredient should be considered investigational rather than an established supplement.
What is the antioxidant activity of Chaetoceros muelleri extract?
In laboratory assays, Chaetoceros muelleri extracts demonstrate ABTS radical scavenging activity up to 94.59 ± 0.04% at a concentration of 2 mg/mL and DPPH radical scavenging up to 65.33 ± 2.90% at 10 mg/mL. The high ABTS activity in the treatment with lowest phenolic content suggests β-glucans contribute independently to antioxidant capacity beyond phenolic compounds. These are in vitro values and do not directly predict antioxidant potency in humans.
Does Chaetoceros muelleri extract affect blood sugar levels?
Purified sulfated polysaccharides (CMSPs) from C. muelleri showed a glycemic index of 49 in an in vitro starch digestion model, classifying them as a low-GI carbohydrate fraction. This suggests potential utility as a blood sugar-moderating food ingredient, but the result comes from a laboratory assay rather than a human glucose tolerance test. Clinical studies measuring postprandial blood glucose responses in human subjects are needed before any glycemic management claims can be supported.
Are there any clinical trials on Chaetoceros muelleri supplements?
No human clinical trials on Chaetoceros muelleri extracts or any of its isolated bioactive fractions have been published as of the current knowledge cutoff. The existing research is entirely preclinical, consisting of in vitro antioxidant assays, physicochemical characterization of sulfated polysaccharides, and aquaculture growth studies. Evidence for efficacy and safety in humans is absent, and the ingredient is best categorized as a preclinical research candidate.
How does Chaetoceros muelleri extract compare to other microalgae supplements for antioxidant support?
Chaetoceros muelleri extract demonstrates exceptional free radical scavenging capacity, with ABTS inhibition reaching 94.59% at 2 mg/mL, which is notably higher than many terrestrial plant extracts. The synergistic action of its sulfated polysaccharides (CMSPs) and β-glucans provides dual-mechanism antioxidant protection, distinguishing it from single-compound microalgae extracts. This combination makes it particularly effective for comprehensive oxidative stress management compared to spirulina or chlorella alone.
Who should consider taking Chaetoceros muelleri extract supplements?
Individuals seeking enhanced antioxidant protection, those managing blood sugar stability, and people with limited access to nutrient-dense seafood sources may benefit from Chaetoceros muelleri supplementation. The low glycemic index profile (GI of 49 for purified CMSPs) makes it especially suitable for those monitoring carbohydrate intake or metabolic health. Athletes and aging adults looking to reduce oxidative stress from exercise or age-related cellular damage may also find this microalgae extract beneficial.
What is the difference between whole Chaetoceros muelleri biomass extract and purified CMSP fractions?
Whole biomass extracts retain multiple bioactive compounds including β-glucans alongside sulfated polysaccharides, offering broader spectrum activity as evidenced by high DPPH inhibition rates (65.33% at 10 mg/mL in nitrogen-enriched forms). Purified CMSP fractions are concentrated derivatives that provide standardized dosing and specific glycemic index benefits (GI of 49), making them more suitable for targeted blood sugar support. Whole biomass may offer synergistic benefits across multiple physiological systems, while purified fractions allow for more precise clinical applications and consistent potency in supplement formulations.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w microalgae-extract-chaetoceros-muelleri curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
